These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2518450)
61. Exposure to malaria affects the regression of hepatosplenomegaly after treatment for Schistosoma mansoni infection in Kenyan children. Booth M; Vennervald BJ; Butterworth AE; Kariuki HC; Amaganga C; Kimani G; Mwatha JK; Otedo A; Ouma JH; Dunne DW BMC Med; 2004 Sep; 2():36. PubMed ID: 15450118 [TBL] [Abstract][Full Text] [Related]
62. Factors controlling the effect of praziquantel on liver fibrosis in Schistosoma mansoni-infected patients. Rahoud SA; Mergani A; Khamis AH; Saeed OK; Mohamed-Ali Q; Dessein AJ; Elwali NE FEMS Immunol Med Microbiol; 2010 Feb; 58(1):106-12. PubMed ID: 20030714 [TBL] [Abstract][Full Text] [Related]
63. Prevalence of schistosomiasis and associated risk factors among school children in Um-Asher Area, Khartoum, Sudan. Hajissa K; Muhajir AEMA; Eshag HA; Alfadel A; Nahied E; Dahab R; Ali SM; Mohammed M; Gaafar M; Mohamed Z BMC Res Notes; 2018 Oct; 11(1):779. PubMed ID: 30382901 [TBL] [Abstract][Full Text] [Related]
64. Characterization of three types of Schistosoma mansoni soluble egg antigen and determination of their immunodiagnostic potential by western blot immunoassay. Hussein HM; el-Gindy IM; Abdel-Hamid DM; el-Wakil HS; Maher KM Egypt J Immunol; 2004; 11(1):65-73. PubMed ID: 15724388 [TBL] [Abstract][Full Text] [Related]
65. The impact of single versus mixed Schistosoma haematobium and S. mansoni infections on morbidity profiles amongst school-children in Taveta, Kenya. Gouvras AN; Kariuki C; Koukounari A; Norton AJ; Lange CN; Ireri E; Fenwick A; Mkoji GM; Webster JP Acta Trop; 2013 Nov; 128(2):309-17. PubMed ID: 23313322 [TBL] [Abstract][Full Text] [Related]
66. Comparative efficacy of one versus two doses of praziquantel on cure rate of Schistosoma mansoni infection and re-infection in Mayuge District, Uganda. Tukahebwa EM; Vennervald BJ; Nuwaha F; Kabatereine NB; Magnussen P Trans R Soc Trop Med Hyg; 2013 Jun; 107(6):397-404. PubMed ID: 23596262 [TBL] [Abstract][Full Text] [Related]
68. Characterizing the Biochemical Response to Schistosoma mansoni Infection and Treatment with Praziquantel in Preschool and School Aged Children. Panic G; Coulibaly JT; Harvey N; Keiser J; Swann J J Proteome Res; 2018 Jun; 17(6):2028-2033. PubMed ID: 29701975 [TBL] [Abstract][Full Text] [Related]
69. Morbidity indicators of Schistosoma mansoni: relationship between infection and anemia in Ugandan schoolchildren before and after praziquantel and albendazole chemotherapy. Koukounari A; Fenwick A; Whawell S; Kabatereine NB; Kazibwe F; Tukahebwa EM; Stothard JR; Donnelly CA; Webster JP Am J Trop Med Hyg; 2006 Aug; 75(2):278-86. PubMed ID: 16896133 [TBL] [Abstract][Full Text] [Related]
70. Hepatosplenomegaly in Kenyan schoolchildren: exacerbation by concurrent chronic exposure to malaria and Schistosoma mansoni infection. Wilson S; Vennervald BJ; Kadzo H; Ireri E; Amaganga C; Booth M; Kariuki HC; Mwatha JK; Kimani G; Ouma JH; Muchiri E; Dunne DW Trop Med Int Health; 2007 Dec; 12(12):1442-9. PubMed ID: 18076550 [TBL] [Abstract][Full Text] [Related]
71. The effect of metrifonate in mixed Schistosoma haematobium and Schistosoma mansoni infections in humans. Doehring E; Poggensee U; Feldmeier H Am J Trop Med Hyg; 1986 Mar; 35(2):323-9. PubMed ID: 3082230 [TBL] [Abstract][Full Text] [Related]
72. Two-year follow-up of Schistosoma mansoni infection and morbidity after treatment with different regimens of oxamniquine and praziquantel. Gryseels B; Nkulikyinka L Trans R Soc Trop Med Hyg; 1989; 83(2):219-28. PubMed ID: 2514474 [TBL] [Abstract][Full Text] [Related]
73. Morbidity in relation to the clinical forms and to intensity of infection in Schistosoma mansoni infections in the Sudan. Salih SY; Marshall TF; Radalowicz A Ann Trop Med Parasitol; 1979 Oct; 73(5):439-49. PubMed ID: 534448 [TBL] [Abstract][Full Text] [Related]
74. The acceptability and safety of praziquantel alone and in combination with mebendazole in the treatment of Schistosoma mansoni and soil-transmitted helminthiasis in children aged 1-4 years in Uganda. Namwanje H; Kabatereine NB; Olsen A Parasitology; 2011 Oct; 138(12):1586-92. PubMed ID: 21349218 [TBL] [Abstract][Full Text] [Related]
75. Gender differences in growth of school-aged children with schistosomiasis and geohelminth infection. Parraga IM; Assis AM; Prado MS; Barreto ML; Reis MG; King CH; Blanton RE Am J Trop Med Hyg; 1996 Aug; 55(2):150-6. PubMed ID: 8780452 [TBL] [Abstract][Full Text] [Related]
76. Nephrotic syndrome associated with Schistosoma mansoni infection. Agarwal BN Del Med J; 1993 Jul; 65(7):429-32. PubMed ID: 8354416 [TBL] [Abstract][Full Text] [Related]
77. Production of monoclonal antibodies against target schistosomal antigen secreted in the urine of Schistosoma mansoni-infected patients. Shaker ZA; Kaddah MA; Hanallah SB; El-Khodary MI Int J Parasitol; 1998 Dec; 28(12):1893-901. PubMed ID: 9925270 [TBL] [Abstract][Full Text] [Related]
78. Influence of Schistosoma mansoni infection on the reproductive capacity of albino mice. Mello RT; Barata CH; Coelho PM; Prata A Rev Soc Bras Med Trop; 1998; 31(6):579-80. PubMed ID: 9859705 [TBL] [Abstract][Full Text] [Related]
79. [Renal involvement in a Salmonella-Schistosoma mansoni association]. Lambertucci JR; Godoy P; Bambirra EA; Neves J; Tafuri WL; Leite VH Rev Soc Bras Med Trop; 1987; 20(2):83-90. PubMed ID: 3148973 [No Abstract] [Full Text] [Related]
80. The effect of dimethylnitrosamine on the activities of renal prenolsulfotransferase and arylsulfatases A and B in Schistosona mansoni infected mice. Hussein NG; Saad AA; Hashem SA; El-Sewedy SM J Egypt Public Health Assoc; 1998; 73(5-6):691-705. PubMed ID: 17217031 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]